We are an international society of national registries, collecting daily practice data to investigate (cost-)effectiveness and safety of systemic immunomodulating therapies and phototherapy in patients with recalcitrant atopic eczema.
In the past we have run consensus exercises to establish our core dataset. We have now set up the DREAM to TREAT project (investigator-led, funded by Pfizer).
We are keen to extent the TREAT Registry Taskfoce family. Do get in touch directly if you would like to get involved: treatregistrytaskforce@gmail.com.
